Eli Lilly (NYSE:LLY) is intensifying its efforts to combat imitation versions of its popular appetite-suppressing drugs, ...

In today's hectic society, when convenience frequently takes precedence over health, keeping a healthy weight has gro ...

The maker of blockbuster appetite-suppressing drugs Mounjaro and Zepbound is seeking to end a regulatory designation that has ...

It’s rare — miraculously rare — that a drug can have such a pronounced effect that its immediate benefits translate into health care savings for years, even decades. To the wonder drugs Harvoni and ...

Type 2 diabetes medication, is proving to be a game-changer in the pharmaceutical industry. With a series of successful ...

Lilly recently announced positive results from a pivotal clinical trial of Mounjaro that could lead to even stronger sales.

The latest results from GLP-1 drugmaker Eli Lilly's clinical trial show that tirzepatide helped people maintain weight loss ...

The most potent weight loss injection, Mounjaro, is coming to Israel. Maariv has learned that the manufacturing company has ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 626.12% and ...

Losing those excess pounds has never been more important, but the difficulty of achieving and maintaining a healthy weight ...

Paid Advertisement Millions of people throughout the world battle to stay at a healthy weight. With obesity rates rising and ...

But the new GLP-1 weight loss medications, such as Ozempic, Mounjaro or Wegovy, may be used in the future, perhaps in concert ...